M4MM
Cronos Introduces Premium Brand to Israeli Medical Cannabis Market
TORONTO – Cronos Group Inc. has launched its premium Cannabis brand in Israel, making five indoor-grown strains available to medical patients through pharmacies across the country. The announcement represents the latest step in Cronos' strategy ...
Washington Senate Committee Advances Home Cannabis Cultivation Bill
WASHINGTON – The Washington State Senate Labor & Commerce Committee has approved Senate Bill 6204, advancing legislation that would permit adults 21-plus to grow limited amounts of Cannabis at home for personal use. Introduced in ...
West Virginia and Mississippi Advance Ibogaine Research Bills
CHARLESTON–JACKSON – Lawmakers in West Virginia and Mississippi have advanced legislation to support research into ibogaine, a psychedelic compound derived from the iboga plant, with the goal of pursuing FDA approval for its use in ...
Arizona Funds Nation’s First Whole-Mushroom Psilocybin Trial Targeting PTSD in Veterans & First Responders
PHOENIX – State officials in Arizona have authorized and financed what amounts to the country's initial controlled study of whole psilocybin mushrooms as a treatment for post-traumatic stress disorder (PTSD) among police officers, firefighters, and ...
Bioxyne Reports Record Revenue, Yet Cash Outflows Climb on Expansion Push
SYDNEY – Bioxyne Limited, an Australian life sciences and wellness products company, posted its highest quarterly revenue on record for the period ended September 30, with sales reaching A$14.1 million, a 210% jump from the ...
Kansas Poll Shows Broad Support for Cannabis Reform
TOPEKA – A recent survey of Kansas residents highlights growing public enthusiasm for Cannabis policy changes, with nearly seven in ten adults endorsing medical use and close to six in ten favoring recreational access. A ...
Cybin Raises $175M in Direct Offering, Reinforcing Psychedelic Pipeline
TORONTO – Cybin Inc., a clinical-stage biopharmaceutical company focused on psychedelic-based treatments for mental health disorders, disclosed a $175 million registered direct offering, drawing commitments from a roster of established biotech investors. The deal, priced ...
Cronos Introduces Premium Brand to Israeli Medical Cannabis Market
TORONTO – Cronos Group Inc. has launched its premium Cannabis brand in Israel, making five indoor-grown strains available to medical patients through pharmacies across the country. The announcement represents the latest step in Cronos' strategy ...
Washington Senate Committee Advances Home Cannabis Cultivation Bill
WASHINGTON – The Washington State Senate Labor & Commerce Committee has approved Senate Bill 6204, advancing legislation that would permit adults 21-plus to grow limited amounts of Cannabis at home for personal use. Introduced in ...
West Virginia and Mississippi Advance Ibogaine Research Bills
CHARLESTON–JACKSON – Lawmakers in West Virginia and Mississippi have advanced legislation to support research into ibogaine, a psychedelic compound derived from the iboga plant, with the goal of pursuing FDA approval for its use in ...
Massachusetts Cannabis Control Commission Officials’ Suspension
LOS ANGELES- In a recent development that has sent ripples through Massachusetts' cannabis sector, the Massachusetts Cannabis Control Commission is grappling with internal instability following the suspension of two senior executives. This turmoil, underscoring potential ...
Algernon Pharmaceuticals Announces $150,000 Private Placement for Working Capital
LOS ANGELES- Algernon Pharmaceuticals Inc., a Canadian clinical stage pharmaceutical development company, has announced a non-brokered private placement aiming to raise $150,000. The offering comprises units priced at $0.075 each, with each unit consisting of ...
MindMed Announces Breakthrough in GAD Treatment with MM-120 in Clinical Trial
LOS ANGELES- Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, has reported promising results from its Phase 2b clinical trial of MM-120 (lysergide d-tartrate) in treating generalized anxiety disorder (GAD). The trial achieved its ...
Trulieve Alabama Recognized as Minority-Owned Business
LOS ANGELES- The Alabama Medical Cannabis Commission (AMCC) has recently taken a significant step forward in the development of the state's medical cannabis industry. In a pivotal move, the AMCC awarded integrated licenses to five ...
Cannabis Bioscience International Holdings (CBIH) Announces SEC Approval for Common Stock Sale
LOS ANGELES- Cannabis Bioscience International Holdings (CBIH), a prominent player in the cannabis bioscience sector, announced on Friday a significant milestone in its financial journey. The company's registration statement on Form S-1, under the Securities ...
Beckley Academy Strengthens Psychedelic Therapy Training Team with New Facilitators
LOS ANGELES- Beckley Academy, a prominent training organization specializing in the preparation of mental health professionals for psychedelic therapies, has announced the addition of two new facilitators to their team, Sara Gael Beauregard and Mary ...
New York’s Legal Cannabis Market Struggles Amidst Regulatory Challenges and Market Saturation
NEW YORK- New York's journey into the legal cannabis market has been fraught with challenges, marked by a series of setbacks including numerous lawsuits and regulatory hurdles. This tumultuous rollout has had a significant impact ...
Los Angeles Confronts Alarming Rise in Fentanyl-Related Fatal Overdoses
LOS ANGELES- In an alarming shift in the landscape of substance misuse, fentanyl has emerged as the leading cause of accidental overdose deaths in Los Angeles County, surpassing methamphetamine for the first time. According to ...
Week In Review: Oakland Tragedy Highlights Urgent Need for Federal Cannabis Policy Reform; Tennessee Hemp Industry Faces Setback from New Regs; AMA Introduces Psychedelic Therapy Codes In FDA Review of Prescription MDMA
LOS ANGELES–Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets: there’s innovation and progress in full swing in some parts of the country, while in other parts, ...
Week In Review: Colorado Voter Initiative Challenges Federal Law on Cannabis Users’ Gun Rights: MedMen Reduces Operations to Four States with Sale of Arizona and Nevada Assets: Biden’s Groundbreaking Pardons Signal a Paradigm Shift in Cannabis Policy and Justice Reform:
LOS ANGELES–Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets: there’s innovation and progress in full swing in some parts of the country, while in other parts, ...
Week In Review: FDA Submission of MDMA-Assisted Therapy Application Aims to Advance Mental Health; Ohio Senate Redirects Cannabis Tax Revenue; Trulieve Are a Minority-Owned Business?
LOS ANGELES–Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets: there’s innovation and progress in full swing in some parts of the country, while in other parts, ...
Arkansas’ Cannabis Revenues Generate Substantial Impact on Education and Community Welfare
LOS ANGELES- The newest review from the Arkansas Medical Marijuana Commission (AMMC) reveals the plan of the state's forward move to repurpose a sizeable sum of the revenue from the current upsurge of the state’s ...
PharmaDrug Inc. Advances Pharmaceutical Innovation with Strategic Acquisition of SecureDose Synthetics
NEW YORK-PharmaDrug Inc., a specialty pharmaceutical company, has recently provided a comprehensive update from CEO Robert Steen on their strategic acquisition of SecureDose Synthetics Inc. This move marks a significant step in PharmaDrug's ongoing efforts ...
Skymint’s Strategic Move Towards Long-term Viability Amidst Financial Struggles
LOS ANGELES- Skymint, a leading cannabis operator in Michigan, is facing significant operational changes as it shuts down its Harvest Park growing and processing plant in Dimondale, near Lansing. The closure, announced in an ...
Curaleaf’s Corporate Strategy for U.S. Unit
New York-based Curaleaf Holdings is embarking on a strategic reorganization of its U.S. subsidiary, Curaleaf USA. This move is part of the company's broader plan to list on the Toronto Stock Exchange, reflecting a significant ...
